Skip to main content
Top

08-03-2024 | Autoimmune Hepatitis | Original Article

A comparative study of uncomplicated acute non-A-E hepatitis with acute viral hepatitis and acute onset autoimmune hepatitis

Authors: Siddhesh Vijay Rane, Shubham Jain, Partha Debnath, Rahul Deshmukh, Sujit Nair, Sanjay Chandnani, Rima Kamat, Pravin Rathi

Published in: Indian Journal of Gastroenterology

Login to get access

Abstract

Background and Aims

Non-A-E hepatitis (NAEH) not leading to acute liver failure (ALF) is poorly documented. The objective was to compare clinical and laboratory features of uncomplicated acute NAEH with acute viral (AVH) and autoimmune hepatitis (AIH) and histopathology in NAEH and AIH.

Methods

Cases of hepatocellular jaundice were included. These were grouped into AVH, AIH and NAEH based on clinical, laboratory and, when indicated, liver biopsy findings. NAEH and AIH were followed up at three months.

Results

Of 336 patients with hepatocellular jaundice, 15 (5%) were NAEH, 25 (7%) acute AIH and 45 (14%) AVH. Among NAEH patients, seven (46.7%) were males with a mean age of presentation 39 years. Jaundice (100%) was the most common presentation of NAEH. Peak bilirubin was 10.7 mg/dL. Peak aspartate and alanine aminotransferase (AST, ALT) were 512 and 670 U/L. Five (33.3%) patients had positive anti-nuclear antibody and one had anti-smooth muscle antibody. Mean immunoglobulin G (IgG) levels were 1829. On liver biopsy, all had ballooning degeneration, four (26.7%) had mild and three (20%) moderate interface hepatitis, four (26.7%) mild lymphoplasmacytic infiltrate, one (6.7%) rosette formation, bridging necrosis in none and stage 1 fibrosis in one. Comparing NAEH with AIH, AIH showed significantly older age at presentation, female predisposition, past history of jaundice, lower ALT, more autoantibodies, higher IgG, higher grade interface hepatitis, lymphoplasmacytic infiltrate, rosette formation and higher bilirubin, AST at three months. NAEH and viral hepatitis had similar features.

Conclusion

Etiology of NAEH is unlikely to be autoimmune and is probably viral, unidentified as yet. Uncomplicated NAEH likely has self-limiting course even without specific treatment.

Graphical abstract

Literature
1.
go back to reference Shalimar, Acharya SK, Kumar R, et al. Acute liver failure of non-A-E viral hepatitis etiology-profile, prognosis, and predictors of outcome. J Clin Exp Hepatol. 2020;10:453–61. Shalimar, Acharya SK, Kumar R, et al. Acute liver failure of non-A-E viral hepatitis etiology-profile, prognosis, and predictors of outcome. J Clin Exp Hepatol. 2020;10:453–61.
2.
go back to reference Bernal W, Hyyrylainen A, Gera A, et al. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol. 2013;59:74–80.CrossRefPubMed Bernal W, Hyyrylainen A, Gera A, et al. Lessons from look-back in acute liver failure? A single centre experience of 3300 patients. J Hepatol. 2013;59:74–80.CrossRefPubMed
3.
go back to reference Donaghy L, Barry FJ, Hunter JG, et al. Clinical and laboratory features and natural history of seronegative hepatitis in a nontransplant centre. Eur J Gastroenterol Hepatol. 2013;25:1159–64.PubMed Donaghy L, Barry FJ, Hunter JG, et al. Clinical and laboratory features and natural history of seronegative hepatitis in a nontransplant centre. Eur J Gastroenterol Hepatol. 2013;25:1159–64.PubMed
4.
go back to reference Ben-Ari Z, Samuel D, Zemel R, et al. Fulminant non-A-G viral hepatitis leading to liver transplantation. Arch Intern Med. 2000;160:388–92.CrossRefPubMed Ben-Ari Z, Samuel D, Zemel R, et al. Fulminant non-A-G viral hepatitis leading to liver transplantation. Arch Intern Med. 2000;160:388–92.CrossRefPubMed
5.
go back to reference Brennan PN, Donnelly MC, Simpson KJ. Systematic review: non A-E, seronegative or indeterminate hepatitis; what is this deadly disease? Aliment Pharmacol Ther. 2018;47:1079–91.CrossRefPubMed Brennan PN, Donnelly MC, Simpson KJ. Systematic review: non A-E, seronegative or indeterminate hepatitis; what is this deadly disease? Aliment Pharmacol Ther. 2018;47:1079–91.CrossRefPubMed
7.
go back to reference Miyake Y, Iwasaki Y, Kobashi H, et al. Autoimmune hepatitis with acute presentation in Japan. Dig Liver Dis. 2010;42:51–4.CrossRefPubMed Miyake Y, Iwasaki Y, Kobashi H, et al. Autoimmune hepatitis with acute presentation in Japan. Dig Liver Dis. 2010;42:51–4.CrossRefPubMed
8.
go back to reference Muratori P, Carbone M, Stangos G, et al. Clinical and prognostic implications of acute onset of autoimmune hepatitis: an Italian multicentre study. Dig Liver Dis. 2018;50:698–702.CrossRefPubMed Muratori P, Carbone M, Stangos G, et al. Clinical and prognostic implications of acute onset of autoimmune hepatitis: an Italian multicentre study. Dig Liver Dis. 2018;50:698–702.CrossRefPubMed
9.
go back to reference Aljumah AA, Al-Ashgar H, Fallatah H, Albenmousa A. Acute onset autoimmune hepatitis: clinical presentation and treatment outcomes. Ann Hepatol. 2019;18:439–44.CrossRefPubMed Aljumah AA, Al-Ashgar H, Fallatah H, Albenmousa A. Acute onset autoimmune hepatitis: clinical presentation and treatment outcomes. Ann Hepatol. 2019;18:439–44.CrossRefPubMed
11.
go back to reference Lanini S, Ustianowski A, Pisapia R, Zumla A, Ippolito G. Viral hepatitis: etiology, epidemiology, transmission, diagnostics, treatment, and prevention. Infect Dis Clin North Am. 2019;33:1045–62.CrossRefPubMed Lanini S, Ustianowski A, Pisapia R, Zumla A, Ippolito G. Viral hepatitis: etiology, epidemiology, transmission, diagnostics, treatment, and prevention. Infect Dis Clin North Am. 2019;33:1045–62.CrossRefPubMed
12.
go back to reference Bunchorntavakul C, Reddy KR. Epstein-Barr virus and cytomegalovirus infections of the liver. Gastroenterol Clin North Am. 2020;49:331–46.CrossRefPubMed Bunchorntavakul C, Reddy KR. Epstein-Barr virus and cytomegalovirus infections of the liver. Gastroenterol Clin North Am. 2020;49:331–46.CrossRefPubMed
13.
go back to reference Then EO, Gayam V, Are VS, Sunkara T, Gaduputi V. Herpes simplex virus hepatitis: a brief review of an Oft-overlooked pathology. Cureus. 2019;11:e4313.PubMedPubMedCentral Then EO, Gayam V, Are VS, Sunkara T, Gaduputi V. Herpes simplex virus hepatitis: a brief review of an Oft-overlooked pathology. Cureus. 2019;11:e4313.PubMedPubMedCentral
15.
go back to reference Sarin SK, Choudhury A, Sharma MK, et al. APASL ACLF Research Consortium (AARC) for APASL ACLF working Party. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL): an update. Hepatol Int. 2019;13:353–90.CrossRefPubMed Sarin SK, Choudhury A, Sharma MK, et al. APASL ACLF Research Consortium (AARC) for APASL ACLF working Party. Acute-on-chronic liver failure: consensus recommendations of the Asian Pacific Association for the Study of the Liver (APASL): an update. Hepatol Int. 2019;13:353–90.CrossRefPubMed
16.
go back to reference Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2020;71:306–33.CrossRefPubMed Crabb DW, Im GY, Szabo G, Mellinger JL, Lucey MR. Diagnosis and treatment of alcohol-associated liver diseases: 2019 practice guidance from the American Association for the Study of Liver Diseases. Hepatology. 2020;71:306–33.CrossRefPubMed
17.
go back to reference Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67:1560–99.CrossRefPubMed Terrault NA, Lok ASF, McMahon BJ, et al. Update on prevention, diagnosis, and treatment of chronic hepatitis B: AASLD 2018 hepatitis B guidance. Hepatology. 2018;67:1560–99.CrossRefPubMed
18.
go back to reference Mack CL, Adams D, Assis DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology. 2020;72:671–722.CrossRefPubMed Mack CL, Adams D, Assis DN, et al. Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American Association for the Study of Liver Diseases. Hepatology. 2020;72:671–722.CrossRefPubMed
19.
go back to reference Ganger DR, Rule J, Rakela J, et al. Acute Liver Failure Study Group. Acute liver failure of indeterminate etiology: a comprehensive systematic approach by an expert committee to establish causality. Am J Gastroenterol. 2018;113:1319.CrossRefPubMedPubMedCentral Ganger DR, Rule J, Rakela J, et al. Acute Liver Failure Study Group. Acute liver failure of indeterminate etiology: a comprehensive systematic approach by an expert committee to establish causality. Am J Gastroenterol. 2018;113:1319.CrossRefPubMedPubMedCentral
20.
go back to reference Alter MJ, Gallagher M, Morris TT, et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team. N Engl J Med. 1997;336:741–6.CrossRefPubMed Alter MJ, Gallagher M, Morris TT, et al. Acute non-A-E hepatitis in the United States and the role of hepatitis G virus infection. Sentinel Counties Viral Hepatitis Study Team. N Engl J Med. 1997;336:741–6.CrossRefPubMed
21.
go back to reference Delić D, Mitrović N, Spurnić AR, Svirtlih NS, Babić JS. Epidemiological characteristics and clinical manifestations of acute non-A-E hepatitis. Vojnosanit Pregl. 2010;67:903–9.CrossRefPubMed Delić D, Mitrović N, Spurnić AR, Svirtlih NS, Babić JS. Epidemiological characteristics and clinical manifestations of acute non-A-E hepatitis. Vojnosanit Pregl. 2010;67:903–9.CrossRefPubMed
22.
go back to reference Paraná R, Codes L, Andrade Z, et al. Clinical, histologic and serologic evaluation of patients with acute non-A-E hepatitis in north-eastern Brazil: is it an infectious disease? Int J Infect Dis. 2003;7:222–30.CrossRefPubMed Paraná R, Codes L, Andrade Z, et al. Clinical, histologic and serologic evaluation of patients with acute non-A-E hepatitis in north-eastern Brazil: is it an infectious disease? Int J Infect Dis. 2003;7:222–30.CrossRefPubMed
23.
go back to reference Nagral N, Joshi V, Baria K, et al. Prevalence of non A to E hepatitis in Mumbai, India. Rev Gastroenterol Peru. 2018;38:49–53.PubMed Nagral N, Joshi V, Baria K, et al. Prevalence of non A to E hepatitis in Mumbai, India. Rev Gastroenterol Peru. 2018;38:49–53.PubMed
25.
go back to reference Sonthalia N, Rathi PM, Jain SS, et al. Natural history and treatment outcomes of severe autoimmune hepatitis. J Clin Gastroenterol. 2017;51:548–56.CrossRefPubMed Sonthalia N, Rathi PM, Jain SS, et al. Natural history and treatment outcomes of severe autoimmune hepatitis. J Clin Gastroenterol. 2017;51:548–56.CrossRefPubMed
26.
go back to reference Abutaleb A, Kottilil S. Hepatitis A: epidemiology, natural history, unusual clinical manifestations, and prevention. Gastroenterol Clin North Am. 2020;49:191–9.CrossRefPubMedPubMedCentral Abutaleb A, Kottilil S. Hepatitis A: epidemiology, natural history, unusual clinical manifestations, and prevention. Gastroenterol Clin North Am. 2020;49:191–9.CrossRefPubMedPubMedCentral
28.
go back to reference Menzo S, Minosse C, Vincenti D, et al. Long-term follow-up of acute hepatitis B: new insights in its natural history and implications for antiviral treatment. Genes (Basel). 2018;9:293.CrossRefPubMedPubMedCentral Menzo S, Minosse C, Vincenti D, et al. Long-term follow-up of acute hepatitis B: new insights in its natural history and implications for antiviral treatment. Genes (Basel). 2018;9:293.CrossRefPubMedPubMedCentral
29.
go back to reference Borse NC, Rathi PM, Sawant P. Hepatitis G virus: an innocent contaminant. J Assoc Physicians India. 1999;47:721–3.PubMed Borse NC, Rathi PM, Sawant P. Hepatitis G virus: an innocent contaminant. J Assoc Physicians India. 1999;47:721–3.PubMed
30.
go back to reference Tassopoulos NC, Papatheodoridis GV, Delladetsima I, Hatzakis A. Clinicopathological features and natural history of acute sporadic non-(A-E) hepatitis. J Gastroenterol Hepatol. 2008;23 8 Pt 1:1208–15. Tassopoulos NC, Papatheodoridis GV, Delladetsima I, Hatzakis A. Clinicopathological features and natural history of acute sporadic non-(A-E) hepatitis. J Gastroenterol Hepatol. 2008;23 8 Pt 1:1208–15.
Metadata
Title
A comparative study of uncomplicated acute non-A-E hepatitis with acute viral hepatitis and acute onset autoimmune hepatitis
Authors
Siddhesh Vijay Rane
Shubham Jain
Partha Debnath
Rahul Deshmukh
Sujit Nair
Sanjay Chandnani
Rima Kamat
Pravin Rathi
Publication date
08-03-2024
Publisher
Springer India
Published in
Indian Journal of Gastroenterology
Print ISSN: 0254-8860
Electronic ISSN: 0975-0711
DOI
https://doi.org/10.1007/s12664-023-01474-1
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.